Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
214 studies found for:    novel influenza a (h1n1)
Show Display Options
Rank Status Study
21 Completed Safety of H1N1 Influenza Vaccination in Pregnant Women
Conditions: Virus Diseases;   Respiratory Tract Infections;   Influenza;   Orthomyxoviridae Infections
Intervention: Biological: split-virion, non-adjuvanted H1N1 vaccine of 15 μg
22 Enrolling by invitation Analysis of the Results From Influenza Rapid Test A Positive and H1N1 Real Time RT-PCR
Condition: H1N1 Influenza Virus
23 Recruiting Respiratory Virus Hospitalization Study (FLU 003 Plus)
Conditions: Influenza;   Novel Respiratory Virus-1 MERS-CoV;   Novel Respiratory Virus-2 SARS-CoV
24 Recruiting Respiratory Virus Outpatient Study (FLU 002 Plus)
Condition: Influenza and Other Novel Respiratory Viruses
25 Completed
Has Results
Relenza® Sentinel Site Monitoring Program in Japan
Condition: Influenza, Human
Intervention: Drug: zanamivir
26 Completed Characteristics and Outcomes of Intensive Care Unit Patients Admitted With Novel H1N1 Influenza or Seasonal Influenza
Conditions: H1N1 Influenza;   Seasonal Influenza
27 Unknown  Antibody Titer Analysis After H1N1 Vaccination in Pediatric Haemato-oncology Patients
Conditions: Serology Analysis;   Novel H1N1 Influenza Vaccination;   Pediatric Haemato-oncology Patients
Intervention: Biological: Influenza A (H1N1) 2009 monovalent vaccine, inactivated
28 Completed Single-blind, Dose-ranging Study of Novel Swine Influenza Virus Vaccine in Japanese Adult Subjects
Condition: Influenza
Intervention: Biological: Adjuvanted cell-derived, inactivated novel swine origin A/H1N1 monovalent subunit influenza virus vaccine
29 Completed Comparative Safety and Immunogenicity of VAX128A, VAC128B and VAX128C Novel H1N1 Influenza Vaccine in Healthy Adults
Condition: Influenza
Interventions: Biological: VAX128;   Biological: Placebo
30 Completed Single-blind, Dose-ranging Study of Novel Swine Influenza Virus Vaccine in Japanese Pediatric Subjects
Condition: Swine-Origin Influenza A H1N1 Virus
Intervention: Biological: Adjuvanted cell-derived, inactivated novel swine origin A/H1N1 monovalent subunit influenza virus vaccine
31 Completed A Study to Validate a New Oral Fluid/Saliva Antibody Test for Novel H1N1v Influenza
Condition: H1N1 Virus
32 Unknown  Immunologic Response to Inactivated Vaccine for Novel H1N1 Virus
Condition: Influenza
Intervention: Biological: Inactivated H1N1 vaccine
33 Unknown  The Impact of Vitamin on the Clinical Course in Cases Infected by Novel H1N1 Influenza Virus A
Condition: H1N1 Influenza
Interventions: Drug: Vitamin (vitamin A 15 mg,C 500 mg, E 400IU);   Drug: Placebo (digestive tablet)
34 Completed
Has Results
Safety Study to Evaluate FluMist in Immunocompromised Children
Condition: Cancer
Interventions: Biological: FluMist;   Biological: Placebo
35 Completed
Has Results
Safety and Immunogenicity of A/H1N1-SOIV (Swine Flu) Vaccine With and Without Adjuvant in Children, Adolescents and Adults (3 to 64 Years)
Condition: Novel 2009 Influenza H1N1
Interventions: Biological: MF59-eH1N1_f;   Biological: eH1N1_f
36 Active, not recruiting Immunogenicity of Novel H1N1 Vaccination Among HIV-Infected Compared to HIV-Uninfected Persons
Conditions: Influenza;   HIV Infections
37 Completed
Has Results
A Phase 2 Study to Evaluate Immune Responses of FluMist®
Condition: Influenza Vaccine
Interventions: Biological: TIV, Trivalent Inactivated Influenza Virus Vaccine;   Biological: FluMist, Influenza Virus Vaccine Live
38 Completed Tolerability and Immunogenicity Study of FLUVAL P H1N1 Flu Vaccine of Omninvest in Children and Adolescents
Conditions: Novel 2009 Influenza H1N1;   Influenza, Human
Interventions: Biological: Vaccination with Fluval P monovalent influenza vaccine;   Biological: Vaccination with Fluval AB;   Biological: Vaccination with Fluval AB Novo
39 Completed
Has Results
Safety of and Immune Response to an H1N1 Influenza Vaccine in HIV Infected Pregnant Women
Conditions: HIV Infections;   H1N1 Influenza Virus
Intervention: Biological: Influenza A (H1N1) monovalent vaccine
40 Completed Immunogenicity, Tolerability and Safety of One or Two Doses of an Adjuvanted Swine-origin A H1N1 Influenza Vaccine in Healthy Subjects 18 or More Years of Age Both Vaccinated and Not Yet Vaccinated Against Seasonal Influenza 2009/10
Condition: Pandemic Influenza Disease
Intervention: Biological: Monovalent A/H1N1 influenza vaccine

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years